Natco Pharma and Orchid Chemicals and Pharmaceuticals have received an adverse observation report, commonly known as Form 483, after inspections conducted in their manufacturing units earlier this year by the US Food and Drug Administration, ... Financial Express, 1 day ago
1 images for "orchid pharma"
Marksans Pharma surged 7 percent (up 200 percent year-to-date) while Orchid Chemicals gained 9 percent as it expects to increase capacity utilisation to 90-100 percent by end of this year.Money Control, 4 weeks ago
SPONSOR Outsourced Pharma West Conference And Exhibition November 10 and 11, 2014 | Hyatt Regency, San Francisco, CA • Who should attend? Pharma and biopharm executives who form and manage outsourcing partnerships. ...Pharmaceutical Online, 2 months ago Orchid seals Hospira deal Business Standard, 2 months ago Hospira complets acquisition of Orchid Pharma's facilities Business Standard, 2 months ago
Orchid Pharma to allocate equity shares to Orchid Healthcare Private Ltd, a promoter Group company, to the tune of Rs 92.17 crore. This is to comply with the requirements to Corporate Debt Restructuring programme approved by the Consortium of ...Business Standard, 1 month ago
The process enables the Chennai-based drug-maker to pay back dues of 2,866 crore to a consortium of lenders over a period of 10 years.Business Line, 2 months ago
It's earnings season. www.indiainfoline.com, a part of the IIFL Group, presents you real-time, comprehensive, and in-depth analysis of company earnings to give you that investment edge. The 'Results Calendar' helps you keep track of all important results. The ...India Infoline, 2 months ago
Orchid Pharma registers turnover of Rs 452 crore in Q2 FY14, an increase of 67% YoY, EBITDA of Rs 108 Crore and EBIT of Rs 51 Crore Financial highlights for Quarter ended June 30, 2014 (Q3 FY14) - Standalone * 1 US$ = Rs 60.49 From the Managing ...Noodls, 1 month ago ORCHID CHEMICALS & PHARMACEUTICALS : Pharma registers turnover of Rs 285 crore in Q3 FY14 4 Traders, 1 month ago
MUMBAI: Shares of pharmaceutical companies continued their good run on Wednesday in an otherwise weak market as investors and traders placed their faith in such stocks, expecting the rally to go on for a while on steady earnings growth. On ...Economic Times, 4 weeks ago Markets end flat Equitymaster.com, 6 days ago Indian share markets remain weak Equitymaster.com, 2 weeks ago Energy and Engg weigh down markets Equitymaster.com, 4 weeks ago
Cipla, Sun Pharma, Lupin, Cadila Healthcare, Aurobindo and Glenmark are up 2-4%, quoting at their lifetime highs. Deepak Korgaonkar | Mumbai August 20, 2014 Last Updated at 13:27 IST Shares of pharmaceutical companies are on a roll with most of the ...Business Standard India, 4 weeks ago
Results Today: Tata Steel , ONGC , Siemens , Unitech , GVK Power , GMR Infrastructure , Voltas , MCX , Financial Technologies , Max India , Shree Renuka Sugars , BGR Energy , Dishman Pharma , Whirlpool, RCF, NCC, MMTC, Lovable Lingerie, Hindustan ...Moneycontrol.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!